No Data
Express News | Shanghai Raas Blood Products Says Controlling Shareholder Changed to Haiyingkang Qingdao Medical Technology, Actual Controller Changed to Haier Group
Express News | Grifols - Is Completely Separate Entity From Scranton, and None of Scranton's Liabilities Are Consolidated at Co's Group
Express News | Grifols - by End June, Liquidity Will Stand at More Than EUR 2.4 Bln Including Sraas Proceeds
Express News | Grifols - Fcf in Q2 2024 Expected to Be Positive, Contributing to Reach EUR 5 Mln FY24 Guidance, Which Includes EUR 480 Mln of Extraordinary Items
Express News | Grifols - at End June 2024, Considering Sraas Proceeds, Leverage Ratio Is Expected to Reach 5.4X Vs. 6.8X in March 2024
Haier Gets Regulatory Nod to Buy Controlling Stake in RAAS Blood Products
No Data
